Weight loss on semaglutide typically plateaus around 60 weeks of treatment, after most people have lost 10% to 15% of their starting weight. This isn’t a sign the medication has failed. It’s a predictable phase where your body’s metabolic defenses catch up to the drug’s effects. The good news: there are several concrete steps that can help you move past it.
Why the Plateau Happens
Your brain doesn’t respond to semaglutide in a static way. It adapts. Research from Vanderbilt University found that even when body weight stabilizes on the drug, the underlying metabolism keeps shifting. Your body is actively working to defend its new, lower weight, which means the same dose that drove early weight loss eventually reaches a point of diminishing returns.
One key mechanism involves eating patterns. Semaglutide keeps individual meals small, but over time, people (and animals in lab studies) compensate by eating more frequently. That gradual increase in meal frequency offsets the smaller portion sizes, and weight loss stalls. Meanwhile, your body appears to shift from burning primarily fat to relying more on carbohydrates for fuel, another adaptation that can slow fat loss even while you’re still taking the medication.
Your resting metabolic rate also drops. Any significant weight loss, whether from medication or dieting, reduces the number of calories your body burns at rest. Animal research published in the American Journal of Physiology found that semaglutide does soften this blow compared to dieting alone. It preserved more lean muscle mass and maintained higher metabolic activity in muscle fibers. But some slowdown is unavoidable, and it contributes to the plateau.
Reassess Your Dose
Wegovy, the weight loss formulation of semaglutide, tops out at 2.4 mg per week. If you haven’t reached that dose yet, your prescriber can increase it. Many people stall at lower doses simply because they haven’t finished the standard titration schedule. If you’re already at 2.4 mg, though, there’s no approved higher dose to move to, which means other strategies become more important.
Adjust What and How You Eat
Because semaglutide suppresses appetite so effectively, many people don’t pay close attention to what they’re eating, only how much. That works fine during the early, rapid weight loss phase. Once you plateau, food quality starts to matter a lot more.
Protein is the priority. Aim for 20 to 30 grams of protein at each meal. This does two things: it helps preserve muscle mass (which keeps your resting metabolism higher), and it has a stronger effect on fullness than carbohydrates or fat, calorie for calorie. If your appetite is still suppressed and meals feel small, making protein the centerpiece ensures you’re getting the most metabolic benefit from limited food intake.
It’s also worth tracking your calories for a week or two, even roughly. The compensatory increase in eating frequency that researchers have observed can be subtle. You may not realize you’re snacking more often or that liquid calories have crept back in. A short period of tracking can reveal patterns you’d otherwise miss.
Add or Intensify Exercise
Exercise alone rarely produces dramatic weight loss, but at the plateau stage, it serves a different purpose: it counteracts the metabolic slowdown. Resistance training is especially valuable here because it builds or maintains the lean tissue that burns calories at rest. A reasonable target is 150 minutes per week of cardio (walking counts) plus two to three sessions of strength training lasting about 30 minutes each.
If you’re already exercising at that level, increasing intensity rather than duration tends to be more effective. Swapping a portion of steady-state walking for intervals, or progressively adding weight to your lifts, forces your body to adapt in ways that support continued fat loss. The goal isn’t to burn off the plateau through sheer effort. It’s to send your muscles the signal to stay metabolically active.
Rule Out Other Causes
Sometimes a stall on semaglutide isn’t really a semaglutide problem. Thyroid disorders, particularly an underactive thyroid, can quietly undermine weight loss. Elevated cortisol from chronic stress or sleep deprivation has a similar effect. Certain medications, including some antidepressants, beta-blockers, and insulin, promote weight gain that can offset what semaglutide is doing. If your weight loss stopped abruptly or you’ve noticed other new symptoms like fatigue, hair thinning, or persistent swelling, a conversation with your prescriber about bloodwork is worthwhile.
Switching to Tirzepatide
Tirzepatide (sold as Zepbound for weight loss) works on two gut hormone pathways instead of one, and head-to-head data shows it outperforms semaglutide by a meaningful margin. In a 72-week randomized trial of 751 people with obesity, those on tirzepatide lost an average of 50 pounds (20.2% of body weight), while those on semaglutide lost 33 pounds (13.7%). Nearly a third of tirzepatide users lost at least 25% of their body weight, compared to 16% on semaglutide. Side effects were similar between the two drugs, with about 44% of people in each group experiencing nausea and 25% reporting abdominal pain.
Smaller studies looking specifically at people who switched after stalling on semaglutide have shown additional weight loss, particularly at higher tirzepatide doses. In one retrospective study, patients who escalated to the 10 mg dose after switching lost an average of about 14 additional pounds. The evidence base for switching is still growing, but the biological rationale is strong: if your brain has adapted to one pathway, activating a second one can restart progress.
Combination Therapies on the Horizon
A newer drug called CagriSema pairs semaglutide with cagrilintide, which mimics a different satiety hormone called amylin. In the REDEFINE 1 trial, CagriSema produced 22.7% weight loss over 68 weeks, compared to 16.1% for semaglutide alone. Over 60% of people on the combination lost at least 20% of their body weight, roughly double the rate seen with semaglutide by itself. This combination isn’t available yet, but it represents the direction treatment is heading: layering multiple hormonal signals to overcome the brain’s adaptive defenses.
Reframing What “Working” Means
A plateau doesn’t mean semaglutide has stopped doing its job. The drug is still suppressing appetite, reducing cravings, and helping maintain whatever weight you’ve already lost. Vanderbilt researchers found that weight regain happens rapidly once treatment stops, precisely because the medication is actively holding a new set point in place. If you’ve lost 10% to 15% of your body weight and maintained it, that’s a clinically significant reduction that lowers your risk of heart disease, type 2 diabetes, and joint problems.
The real question isn’t whether semaglutide is still working. It’s whether you want to pursue additional weight loss beyond what this particular drug can deliver at its current dose. If the answer is yes, the options above, from lifestyle adjustments to medication switches, give you a clear path forward.